PrecisCa

PrecisCa supports patients, their caregivers, and health care providers at every step of their cancer journeys from diagnosis to remission, with up-to-date education on the latest advancements in cancer care and access to leading specialists to analyze patient scenarios

https://precisca.com/

 

PrecisCa
Avatar

Predictive Survival Factors for Patients With Urothelial Carcinoma Who Progress After Platinum-Based Therapy and Are Started on Immunotherapy

By PrecisCa FEATURING Matthew Rettig
By PrecisCa FEATURING Matthew Rettig
57 views
December 28, 2022
Comments 0
Login to view comments. Click here to Login
GU
14:29

66 y/o Woman With Newly Diagnosed Stage IV ccRCC With Metastases to …

PrecisCa

L. Littlejohn, V. Master, M. Abramowitz

77 views
14:14

GU Tumor Board: 61 y/o Male With mRCC With Disease Progression After…

PrecisCa

M. Rettig, S. Slovin, T. Fraum, J. Abel, P. Patel

206 views
08:16

Preferred Modality for Follow-Up Imaging After Definitive Treatment …

PrecisCa

C. Lynn Siegel

234 views
07:50

Treatment Approach for Patients With mCSPC

PrecisCa

M. Rettig

188 views
07:00

Predictive Survival Factors for Patients With Urothelial Carcinoma W…

PrecisCa

M. Rettig

57 views
05:32

When to Use Genomic Testing for Prostate Cancer

PrecisCa

P. Patel

143 views
05:04

Comparing Low-Dose Rate to High-Dose Rate Brachytherapy: When Is LDR…

PrecisCa

P. Patel

19 views
16:12

GU Tumor Board: 59 y/o Male Presented With Gross Hematuria and Metas…

PrecisCa

B. Rini, C. Lynn Siegel, C. Shah, J. Abel, A. Drakaki

167 views
07:47

GU Tumor Board: 60 y/o Male Presented With Groin Mass and Diagnosed …

PrecisCa

B. Rini, C. Lynn Siegel, C. Shah, J. Abel, A. Drakaki

71 views